Sponsor

AvenCell Europe GmbH

Clinical research sponsor

Published trials3

Recruiting shown0

Roles2

SourceClinicalTrials.gov

Clinical trials

3 shown

Dose-escalating Trial With UniCAR02-T Cells and PSMA Target Module (TMpPSMA) in Patients With Progressive Disease After Standard Systemic Therapy in Cancers With Positive PSMA MarkerNCT04633148 · lead sponsor · 2020-11-23

TERMINATED

Study With Bispecific Antibody Engaging T-cells, in Patients With Progressive Cancer Diseases With Positive PSCA MarkerNCT03927573 · lead sponsor · 2019-04-15

TERMINATED

Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical TrialsNCT07474051 · collaborator · 2026-01-29

ENROLLING_BY_INVITATION

Sponsor roles

lead sponsor2

collaborator1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.